TP53is not a prognostic marker—clinical consequences of a generally disregarded fact-Reference-Cited by-同舟云学术

TP53is not a prognostic marker—clinical consequences of a generally disregarded fact

Published:2018-08-15 Issue:1 Volume:1434 Page:46-53
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Braunschmid Tamara¹^ORCID,Kührer Irene²,Mittlböck Martina³,Westerhoff Maria⁴,Kappel‐Latif Sonja⁵,Brammen Lindsay¹,Krishnadath Kausilia K.⁶,Phillips Wayne A.⁷,Gnant Michael¹,Kandioler Daniela¹

Affiliation:

1. Department of SurgeryMedical University of Vienna Vienna Austria

2. Department of Internal Medicine IIIMedical University of Vienna Vienna Austria

3. Center for Medical StatisticsInformaticsand Intelligent SystemsMedical University of Vienna Vienna Austria

4. Department of PathologyUniversity of Michigan Ann Arbor Michigan

5. Department of SurgeryResearch LaboratoriesMedical University of Vienna Vienna Austria

6. Department of Translational GastroenterologyAcademic Medical CenterUniversity of Amsterdam Amsterdam the Netherlands

7. Peter MacCallum Cancer Centre Melbourne Victoria Australia

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.13947

Reference36 articles.

1. Gene expression‐based prognostic and predictive markers for breast cancer: a primer for practicing pathologists;Kim C.;Arch. Pathol. Lab. Med.,2009

2. International Agency for Research on Cancer W.H.O. Somatic mutations. Accessed September 1 2017.http://p53.iarc.fr/TP53SomaticMutations.aspx.

3. p53 Mutations in Human Cancers

4. P53 abnormalities and outcomes in colorectal cancer: a systematic review

5. Prognostic Value of p53 Genetic Changes in Colorectal Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?;Breast Cancer Research and Treatment;2024-01-25

2. Auf dem Weg zur Präzisionsonkologie: Biomarker, molekulargenetische Tumorprofile und Big Data;Digitale Transformation von Dienstleistungen im Gesundheitswesen VII;2020